
Use of AI in drug R&D limited in life sciences, survey says
The use of artificial intelligence is widespread across life sciences organisations but its use in drug research and development is limited, analysis finds. Research by The Pistoia Alliance, a not-for-profit life sciences advocacy group, shows 30% of life sciences professionals say their organisation has implemented an enterprise-wide AI… Read More















